Pediatric Surgery International

, Volume 23, Issue 4, pp 315–322

Mature and immature teratomas: results of the first paediatric Italian study

  • Margherita Lo Curto
  • Paolo D’Angelo
  • Giovanni Cecchetto
  • Catherine Klersy
  • Patrizia Dall’Igna
  • Antonia Federico
  • Fortunato Siracusa
  • Rita Alaggio
  • Gabriella Bernini
  • Massimo Conte
  • Tina De Laurentis
  • Andrea Di Cataldo
  • Alessandro Inserra
  • Nicola Santoro
  • Paolo Tamaro
  • Paolo Indolfi
Original Article

DOI: 10.1007/s00383-007-1890-1

Cite this article as:
Lo Curto, M., D’Angelo, P., Cecchetto, G. et al. Pediatr Surg Int (2007) 23: 315. doi:10.1007/s00383-007-1890-1

Abstract

Teratoma is the most common germ cell tumour in childhood; mature (MT) and immature teratomas (IT) are benign tumours, but if they recur, they can be in some cases malignant. The aim of this paper is to evaluate Italian patients with MT and IT enrolled from 1991 to 2001, in a prospective multicentric study. One hundred and eighty-three patients, observed in 15 Italian Centers of Paediatric Oncology and three Paediatric Surgical Units were enrolled. Clinical data, treatment and results were all analysed. Initial evaluation and subsequent follow up included clinical examination, tumour markers and imaging procedures. Surgical resection was recommended for all the tumours. Histology was centrally reviewed and IT was classified as grading 1–3. Chemotherapy (CT) with Vinblastine, D-actinomycin and cyclophosphamide was indicated for extra-testicular IT grade 2 or 3. MT was diagnosed in 127 patients (93 F and 34 M, age 1–192 months, median 24): 58 patients had gonadic tumour (23 testicular, 35 ovaric), 69 extragonadic (45 sacrococcygeal, 11 mediastinic, 7 retroperitoneal, 6 in other sites). A complete resection was performed in 117 patients, a partial resection in eight patients and biopsy in one. IT was diagnosed in 56 patients (34 F, 22 M, age 1–168 months, median 7). The T grading was 1 in 14 cases, 2 in 26, 3 in 16; 28 had gonadic T (17 ovary, 11 testis), 28 extragonadic (sacrococcygeal 19, mediastinic 3, retroperitoneal 2, other sites 4). CT was administered in eight patients; 15/182 patients relapsed (1 in a metastatic site) and in 5/15 the relapse showed malignant histology. Seven MT (5.5%) relapsed (five sacrococcygeal, one retroperitoneal, one mediastinic): surgery at diagnosis had been complete in five and with residual in two; the relapse was malignant in two patients with sacrococcygeal (sc) tumours, who had a complete resection and a partial resection respectively. Eight IT (14.2%) relapsed (four ovary, three sc, one retroperitoneal). The initial surgical resection had been complete in one, with residual in six, and a biopsy had been performed in one. A malignant recurrence occurred in two patients with sc tumours (after partial resection in one and after biopsy + CT in one) and in one patient with ovarian IT after a partial resection. All the patients underwent surgical excision of the recurred mass; CT according to Protocol for Malignant GCT was administered to those who had malignant recurrence; 122/126 patients with MT and 53/56 with IT are alive without disease with a follow up of 8–144 months (median 56). Two patients with malignant relapse (one with sc MT, one with sc IT) died because of the progression of the disease. Another two died due to severe malformations (one MT, one IT) and three were lost to follow up (two MT, one IT). The overall survival (OS) at 10 years is 98% (95% CI 93.9–99.4); the event free survival (EFS) is 90.4% (95 CI 84.8–94.0). At Cox analysis no significant difference in EFS was found regarding age and site of the primary tumour, while females (P = 0.011), patients with grade 1–3 histology (P = 0.025) and patients with incomplete resection appeared at higher risk of death or relapse (P < 0.001), with a seven, three and eightfold increase in risk, respectively. Our data showed that incomplete resection and female gender are important risk factors for relapse or death, more so than IT histology. The number of patients treated with CT is not sufficient to evaluate the efficacy of CT in avoiding malignant relapse.

Keywords

Mature teratomaImmature teratomaChildhood tumoursTreatment and outcome

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Margherita Lo Curto
    • 1
    • 15
  • Paolo D’Angelo
    • 2
  • Giovanni Cecchetto
    • 3
  • Catherine Klersy
    • 4
  • Patrizia Dall’Igna
    • 3
  • Antonia Federico
    • 1
  • Fortunato Siracusa
    • 5
  • Rita Alaggio
    • 6
  • Gabriella Bernini
    • 7
  • Massimo Conte
    • 8
  • Tina De Laurentis
    • 9
  • Andrea Di Cataldo
    • 10
  • Alessandro Inserra
    • 11
  • Nicola Santoro
    • 12
  • Paolo Tamaro
    • 13
  • Paolo Indolfi
    • 14
  1. 1.Paediatric DepartmentUniversity of PalermoPalermoItaly
  2. 2.Unit of Paediatric Hematology and Oncology“G. Di Cristina” Children HospitalPalermoItaly
  3. 3.Paediatric Surgery DepartmentUniversity of PaduaPaduaItaly
  4. 4.Biometry and Clinical EpidemiologyIRCCS San Matteo HospitalPaviaItaly
  5. 5.Paediatric Surgery DepartmentUniversity of PalermoPalermoItaly
  6. 6.Section of Pathology, Department of Oncologic SciencesUniversity of PaduaPaduaItaly
  7. 7.Unit of Paediatric OncologyMeyer HospitalFlorenceItaly
  8. 8.Unit of Paediatric OncologyGaslini InstituteGenoaItaly
  9. 9.Unit of Paediatric Oncology“Bambin Gesù” HospitalRomeItaly
  10. 10.Department of Paediatric Hematology and OncologyUniversity of CataniaCataniaItaly
  11. 11.Paediatric Surgery Department“Bambin Gesù” Children HospitalRomeItaly
  12. 12.Department of Paediatric Hematology and OncologyUniversity of BariBariItaly
  13. 13.Paediatric Hematology and Oncology DepartmentUniversity of TriesteTriesteItaly
  14. 14.Paediatric Hematology and Oncology DepartmentUniversity of NaplesNaplesItaly
  15. 15.Dipartimento di PediatriaIstituto Materno-InfantilePalermoItaly